Somatostatin receptor type 2 — Drug Target
All drugs that target Somatostatin receptor type 2 — marketed and clinical-stage. Includes 1 drug classes acting on this target.
Drug classes
Marketed (4)
- Somatuline Depot · Ipsen Pharma · Somatostatin Analog · Other
Somatuline Depot works by mimicking the natural hormone somatostatin to block the production of excess growth hormone. - Ga 68 Dotatate · Uihc Pet Imaging · Oncology
- Sandostatin · Novartis · Somatostatin Analog · Oncology
Sandostatin works by mimicking the natural hormone somatostatin to inhibit the release of various hormones and growth factors. - Lutathera · Aaa Usa Inc · Oncology
Lutathera works by binding to somatostatin receptors on neuroendocrine tumor cells, delivering a radioactive dose that kills the cells.